content top

Intravitreal Injection of Bevacizumab for the Treatment of Choroidal Neovascularization Secondary to Angioid Streaks

Salim Ben Yahia, Rim Kahloun, Salma Gargouri, Rim Ghrissi, Riadh Messaoud, Moncef Khairallah (Monastir, Tunisia) Advantages: To manage choroidal neovascularization (CNV) secondary to angioid streaks with intravitreal injection of bevacizumab. Methods: Eight eyes of 8 patients with CNV secondary to angioid streaks were treated with intravitreal injection of 1.25 mg (0.05 mL) of bevacizumab. Main outcome measures included changes in...

Read More

Intravitreal Injection of Bevacizumab for the Treatment of Inflammatory Choroidal Neovascularization

Salim Ben Yahia, Bechir Jelliti, Rim Kahloun, Rim Ghrissi, Salah Jenzeri, Moncef Khairallah (Monastir, Tunisia) Advantages: To manage inflammatory choroidal neovascularization (CNV) with intravitreal injection of bevacizumab, since conventional therapeutic options, including laser photocoagulation, surgery, corticosteroids, and verteporfin therapy, have potential limitations and are associated with a high rate of recurrences. Methods:...

Read More
content top